We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lifevantage Corporation | NASDAQ:LFVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.16 | 6.75 | 7.45 | 0 | 12:00:00 |
ý
|
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
COLORADO
|
|
90-0224471
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
Large accelerated filer
|
¨
|
Accelerated filer
|
ý
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
•
|
We may not succeed in expanding our operations;
|
•
|
Inability to conform to government regulations in existing markets;
|
•
|
We may not succeed in growing existing markets or opening new international markets;
|
•
|
Inability to manage our growth and expansion;
|
•
|
Disruptions in our information technology systems;
|
•
|
Claims against us as a result of our independent distributors failing to comply with our policies and procedures;
|
•
|
Inability of new products to gain distributor and market acceptance;
|
•
|
International trade or foreign exchange restrictions, increased tariffs, foreign currency exchange;
|
•
|
Deterioration of global economic conditions;
|
•
|
Inability to maintain appropriate level of internal control over financial reporting;
|
•
|
We may be unable to raise additional capital if needed;
|
•
|
Exposure to environmental liabilities stemming from past operations and property ownership;
|
•
|
Significant dependence upon a single product;
|
•
|
The impact of our debt service obligations and restrictive debt covenants;
|
•
|
Our inability to obtain high quality raw material for our products;
|
•
|
Improper actions by our independent distributors that violate laws or regulations;
|
•
|
Our inability to retain independent distributors or to attract new independent distributors on an ongoing basis;
|
•
|
We may be subject to a product recall;
|
•
|
Our dependence on third parties to manufacture our products;
|
•
|
Significant government regulations on network marketing activities;
|
•
|
Third party and governmental actions involving our network marketing sales activities;
|
•
|
Our direct selling program could be found to not be in compliance with current or newly adopted laws or regulations;
|
•
|
Unfavorable publicity on our business or products;
|
•
|
Legal proceedings may be expensive and time consuming;
|
•
|
Regulations governing the production or marketing of our products;
|
•
|
Our business is subject to strict government regulations;
|
•
|
We are subject to the risk of investigatory and enforcement action by the federal trade commission;
|
•
|
Government authorities may question our tax positions or transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business;
|
•
|
Failure to comply with anti-corruption laws;
|
•
|
Loss of key personnel;
|
•
|
Competition in the dietary supplement market;
|
•
|
Our inability to protect our intellectual property rights;
|
•
|
Third party claims that we infringe on their intellectual property;
|
•
|
Product liability claims against us;
|
•
|
Economic, political, foreign exchange and other risks associated with international operations;
|
•
|
Significant dilution of outstanding voting shares if holders of our existing warrants and options exercise their securities for shares of common stock;
|
•
|
Volatility of the market price of our common stock;
|
•
|
We have not paid dividends on our capital stock, and we do not currently anticipate paying dividends in the foreseeable future; and
|
•
|
Other factors not specifically described above, including the other risks, uncertainties, and contingencies described under “Part II. Item 1A — Risk Factors” of this Quarterly Report on Form 10-Q or under “Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Items 1, 1A and 7 of our Annual Report on Form 10-K for the year ended June 30, 2013.
|
|
|
|
|
|
PAGE
|
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 5.
|
||
Item 6.
|
||
|
|
As of,
|
||||||
|
March 31, 2014
|
|
June 30, 2013
|
||||
(In thousands, except per share data)
|
|
|
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
35,681
|
|
|
$
|
26,299
|
|
Accounts receivable
|
2,606
|
|
|
1,789
|
|
||
Income tax receivable
|
1,511
|
|
|
2,150
|
|
||
Inventory
|
8,576
|
|
|
10,524
|
|
||
Current deferred income tax asset
|
2,885
|
|
|
2,885
|
|
||
Prepaid expenses and deposits
|
4,999
|
|
|
2,294
|
|
||
Total current assets
|
56,258
|
|
|
45,941
|
|
||
|
|
|
|
||||
Property and equipment, net
|
7,183
|
|
|
5,692
|
|
||
Intangible assets, net
|
1,697
|
|
|
1,747
|
|
||
Deferred debt offering costs, net
|
1,413
|
|
|
—
|
|
||
Long-term deferred income tax asset
|
730
|
|
|
730
|
|
||
Other long-term assets
|
3,021
|
|
|
1,374
|
|
||
TOTAL ASSETS
|
$
|
70,302
|
|
|
$
|
55,484
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable
|
$
|
2,641
|
|
|
$
|
5,171
|
|
Commissions payable
|
9,595
|
|
|
7,564
|
|
||
Other accrued expenses
|
8,369
|
|
|
7,831
|
|
||
Short-term portion of debt
|
4,700
|
|
|
—
|
|
||
Total current liabilities
|
25,305
|
|
|
20,566
|
|
||
|
|
|
|
||||
Long-term debt
|
|
|
|
||||
Principal amount
|
41,125
|
|
|
—
|
|
||
Less: unamortized discount
|
(1,098
|
)
|
|
—
|
|
||
Long-term debt, net of unamortized discount
|
40,027
|
|
|
—
|
|
||
Other long-term liabilities
|
2,243
|
|
|
973
|
|
||
Total liabilities
|
67,575
|
|
|
21,539
|
|
||
Commitments and contingencies
|
|
|
|
||||
Stockholders’ equity
|
|
|
|
||||
Preferred stock — par value $0.001 per share, 50,000 shares authorized, no shares issued or outstanding
|
—
|
|
|
—
|
|
||
Common stock — par value $0.001 per share, 250,000 shares authorized and 104,024 and 117,088 issued and outstanding as of March 31, 2014 and June 30, 2013, respectively
|
104
|
|
|
121
|
|
||
Additional paid-in capital
|
113,692
|
|
|
110,413
|
|
||
Accumulated deficit
|
(110,593
|
)
|
|
(76,476
|
)
|
||
Accumulated other comprehensive loss
|
(476
|
)
|
|
(113
|
)
|
||
Total stockholders’ equity
|
2,727
|
|
|
33,945
|
|
||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
70,302
|
|
|
$
|
55,484
|
|
|
For the Three Months Ended
March 31, |
|
For the Nine Months Ended
March 31, |
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
(In thousands, except per share data)
|
|
|
|
|
|
|
|
||||||||
Sales, net
|
$
|
55,064
|
|
|
$
|
50,370
|
|
|
$
|
157,930
|
|
|
$
|
156,667
|
|
Cost of sales
|
8,459
|
|
|
7,330
|
|
|
24,212
|
|
|
23,936
|
|
||||
Product recall costs
|
—
|
|
|
(461
|
)
|
|
—
|
|
|
5,418
|
|
||||
Gross profit
|
46,605
|
|
|
43,501
|
|
|
133,718
|
|
|
127,313
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Sales and marketing
|
32,483
|
|
|
29,844
|
|
|
92,510
|
|
|
88,976
|
|
||||
General and administrative
|
8,470
|
|
|
8,370
|
|
|
23,432
|
|
|
23,227
|
|
||||
Research and development
|
655
|
|
|
848
|
|
|
1,546
|
|
|
2,105
|
|
||||
Depreciation and amortization
|
530
|
|
|
499
|
|
|
1,527
|
|
|
1,180
|
|
||||
Total operating expenses
|
42,138
|
|
|
39,561
|
|
|
119,015
|
|
|
115,488
|
|
||||
Operating income
|
4,467
|
|
|
3,940
|
|
|
14,703
|
|
|
11,825
|
|
||||
Other income (expense), net:
|
|
|
|
|
|
|
|
||||||||
Interest and other income (expense), net
|
(1,278
|
)
|
|
122
|
|
|
(1,605
|
)
|
|
(426
|
)
|
||||
Total other income (expense)
|
(1,278
|
)
|
|
122
|
|
|
(1,605
|
)
|
|
(426
|
)
|
||||
Net income before income taxes
|
3,189
|
|
|
4,062
|
|
|
13,098
|
|
|
11,399
|
|
||||
Income tax expense
|
(695
|
)
|
|
(646
|
)
|
|
(4,066
|
)
|
|
(3,609
|
)
|
||||
Net income
|
$
|
2,494
|
|
|
$
|
3,416
|
|
|
$
|
9,032
|
|
|
$
|
7,790
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.02
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.07
|
|
Diluted
|
$
|
0.02
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.06
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
101,594
|
|
|
112,806
|
|
|
107,385
|
|
|
112,203
|
|
||||
Diluted
|
106,578
|
|
|
124,985
|
|
|
113,717
|
|
|
125,371
|
|
||||
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment
|
103
|
|
|
(87
|
)
|
|
(363
|
)
|
|
(24
|
)
|
||||
Other comprehensive income (loss), net of tax:
|
$
|
103
|
|
|
$
|
(87
|
)
|
|
$
|
(363
|
)
|
|
$
|
(24
|
)
|
Comprehensive income
|
$
|
2,597
|
|
|
$
|
3,329
|
|
|
$
|
8,669
|
|
|
$
|
7,766
|
|
|
Common stock
|
|
Additional
paid-in
capital
|
|
Accumulated
deficit
|
|
Accumulated
other
comprehensive
loss
|
|
Total
|
|||||||||||||
|
Shares
|
|
Amount
|
|
||||||||||||||||||
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balances, June 30, 2013
|
117,088
|
|
|
$
|
121
|
|
|
$
|
110,413
|
|
|
$
|
(76,476
|
)
|
|
$
|
(113
|
)
|
|
$
|
33,945
|
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
2,044
|
|
|
—
|
|
|
—
|
|
|
2,044
|
|
|||||
Exercise of options and warrants
|
4,654
|
|
|
4
|
|
|
1,235
|
|
|
—
|
|
|
—
|
|
|
1,239
|
|
|||||
Issuance of shares related to restricted stock
|
225
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Shares canceled or surrendered as payment of tax withholding
|
(453
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Repurchase of company stock
|
(17,490)
|
|
|
(21
|
)
|
|
—
|
|
|
(43,149
|
)
|
|
—
|
|
|
(43,170
|
)
|
|||||
Currency translation adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(363
|
)
|
|
(363
|
)
|
|||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
9,032
|
|
|
—
|
|
|
9,032
|
|
|||||
Balances, March 31, 2014
|
104,024
|
|
|
$
|
104
|
|
|
$
|
113,692
|
|
|
$
|
(110,593
|
)
|
|
$
|
(476
|
)
|
|
$
|
2,727
|
|
|
For the Nine Months Ended
March 31, |
||||||
|
2014
|
|
2013
|
||||
(In thousands)
|
|
|
|
||||
Cash Flows from Operating Activities:
|
|
|
|
||||
Net income
|
$
|
9,032
|
|
|
$
|
7,790
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
1,527
|
|
|
1,180
|
|
||
Stock-based compensation
|
2,169
|
|
|
1,635
|
|
||
Amortization of deferred financing fees
|
99
|
|
|
—
|
|
||
Amortization of debt discount
|
76
|
|
|
—
|
|
||
Impairment of inventory
|
—
|
|
|
4,155
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Increase in accounts receivable
|
(189
|
)
|
|
(1,048
|
)
|
||
Decrease/(increase) in inventory
|
1,858
|
|
|
(827
|
)
|
||
Increase in prepaid expenses and deposits
|
(2,719
|
)
|
|
(4,735
|
)
|
||
Increase in other long-term assets
|
(1,645
|
)
|
|
(1,077
|
)
|
||
Increase/(decrease) in accounts payable
|
(2,527
|
)
|
|
993
|
|
||
Increase in accrued expenses
|
2,596
|
|
|
1,559
|
|
||
Increase/(decrease) in other long-term liabilities
|
(100
|
)
|
|
442
|
|
||
Net Cash Provided by Operating Activities
|
10,177
|
|
|
10,067
|
|
||
Cash Flows from Investing Activities:
|
|
|
|
||||
Purchase of equipment
|
(1,671
|
)
|
|
(4,625
|
)
|
||
Net Cash Used in Investing Activities
|
(1,671
|
)
|
|
(4,625
|
)
|
||
Cash Flows from Financing Activities:
|
|
|
|
||||
Proceeds from term loan
|
45,825
|
|
|
—
|
|
||
Payment of deferred financing fees
|
(1,511
|
)
|
|
—
|
|
||
Repurchase of company stock
|
(43,170
|
)
|
|
(4,893
|
)
|
||
Payment on term loan
|
(1,175
|
)
|
|
—
|
|
||
Exercise of options and warrants
|
1,239
|
|
|
2,066
|
|
||
Net Cash Provided by (Used in) Financing Activities
|
1,208
|
|
|
(2,827
|
)
|
||
Foreign Currency Effect on Cash
|
(332
|
)
|
|
(24
|
)
|
||
Increase in Cash and Cash Equivalents:
|
9,382
|
|
|
2,591
|
|
||
Cash and Cash Equivalents — beginning of period
|
26,299
|
|
|
24,648
|
|
||
Cash and Cash Equivalents — end of period
|
$
|
35,681
|
|
|
$
|
27,239
|
|
Non Cash Investing and Financing Activities:
|
|
|
|
||||
Increase in property and equipment/other long-term liabilities
|
$
|
1,386
|
|
|
$
|
376
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|
|
|
||||
Cash paid for interest expense
|
$
|
1,821
|
|
|
$
|
—
|
|
Cash paid for income taxes
|
$
|
3,461
|
|
|
$
|
6,370
|
|
|
March 31,
2014 |
|
June 30,
2013 |
||||
Finished goods
|
$
|
5,208
|
|
|
$
|
5,273
|
|
Raw materials
|
3,368
|
|
|
5,251
|
|
||
Total inventory
|
$
|
8,576
|
|
|
$
|
10,524
|
|
|
Three Months Ended
March 31, |
|
Nine Months Ended
March 31, |
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
2,494
|
|
|
$
|
3,416
|
|
|
$
|
9,032
|
|
|
$
|
7,790
|
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
Basic weighted average common shares outstanding
|
101,594
|
|
|
112,806
|
|
|
107,385
|
|
|
112,203
|
|
||||
Effect of dilutive securities:
|
|
|
|
|
|
|
|
||||||||
Stock awards and options
|
1,974
|
|
|
3,802
|
|
|
2,929
|
|
|
4,586
|
|
||||
Warrants
|
3,010
|
|
|
8,377
|
|
|
3,403
|
|
|
8,582
|
|
||||
Diluted weighted average common shares outstanding
|
106,578
|
|
|
124,985
|
|
|
113,717
|
|
|
125,371
|
|
||||
Net income per share, basic
|
$
|
0.02
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.07
|
|
Net income per share, diluted
|
$
|
0.02
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.06
|
|
|
Three Months Ended
March 31, |
|
Nine Months Ended
March 31, |
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Americas
|
$
|
32,641
|
|
|
$
|
33,098
|
|
|
$
|
101,557
|
|
|
$
|
97,720
|
|
Asia/Pacific
|
22,423
|
|
|
17,272
|
|
|
56,373
|
|
|
58,947
|
|
||||
Total revenues
|
$
|
55,064
|
|
|
$
|
50,370
|
|
|
$
|
157,930
|
|
|
$
|
156,667
|
|
|
Three Months Ended
March 31, |
|
Nine Months Ended
March 31, |
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
United States
|
$
|
31,619
|
|
|
$
|
32,721
|
|
|
$
|
98,415
|
|
|
$
|
96,779
|
|
Japan
|
$
|
19,202
|
|
|
$
|
15,284
|
|
|
$
|
48,122
|
|
|
$
|
55,080
|
|
Year Ending June 30,
|
Amount
|
||
2014 (remaining three months ending June 30, 2014)
|
$
|
1,175
|
|
2015
|
4,700
|
|
|
2016
|
4,700
|
|
|
2017
|
4,700
|
|
|
2018
|
4,700
|
|
|
Thereafter
|
25,850
|
|
|
|
$
|
45,825
|
|
|
Active Preferred Customers By Region
|
|
|
|
|
||||||||||||
|
March 31,
|
|
|
|
|
||||||||||||
|
2014
|
|
2013
|
|
Change from Prior Year
|
|
Percent Change
|
||||||||||
Americas
|
106,000
|
|
|
79.1
|
%
|
|
115,000
|
|
|
82.1
|
%
|
|
(9,000
|
)
|
|
(7.8
|
)%
|
Asia/Pacific
|
28,000
|
|
|
20.9
|
%
|
|
25,000
|
|
|
17.9
|
%
|
|
3,000
|
|
|
12.0
|
%
|
|
134,000
|
|
|
100.0
|
%
|
|
140,000
|
|
|
100.0
|
%
|
|
(6,000
|
)
|
|
(4.3
|
)%
|
|
Three Months Ended
March 31, |
|
|
|
Nine Months Ended
March 31, |
|
|
||||||||||||||
|
2014
|
|
2013
|
|
% Change
|
|
2014
|
|
2013
|
|
% Change
|
||||||||||
United States
|
$
|
31,619
|
|
|
$
|
32,721
|
|
|
(3.37
|
)%
|
|
$
|
98,415
|
|
|
$
|
96,779
|
|
|
1.7
|
%
|
Other
|
1,022
|
|
|
377
|
|
|
171.09
|
%
|
|
3,142
|
|
|
941
|
|
|
233.9
|
%
|
||||
Americas Total
|
$
|
32,641
|
|
|
$
|
33,098
|
|
|
(1.4
|
)%
|
|
$
|
101,557
|
|
|
$
|
97,720
|
|
|
3.9
|
%
|
|
Three Months Ended
March 31, |
|
|
|
Nine Months Ended
March 31, |
|
|
||||||||||||||
|
2014
|
|
2013
|
|
% Change
|
|
2014
|
|
2013
|
|
% Change
|
||||||||||
Japan
|
$
|
19,202
|
|
|
$
|
15,284
|
|
|
25.6
|
%
|
|
$
|
48,122
|
|
|
$
|
55,080
|
|
|
(12.6
|
)%
|
Hong Kong
|
2,278
|
|
|
1,203
|
|
|
89.4
|
%
|
|
5,872
|
|
|
1,203
|
|
|
388.1
|
%
|
||||
Other
|
943
|
|
|
785
|
|
|
20.1
|
%
|
|
2,379
|
|
|
2,664
|
|
|
(10.7
|
)%
|
||||
Asia/Pacific Total
|
$
|
22,423
|
|
|
$
|
17,272
|
|
|
29.8
|
%
|
|
$
|
56,373
|
|
|
$
|
58,947
|
|
|
(4.4
|
)%
|
|
For the Three Months Ended
March 31, |
|
For the Nine Months Ended
March 31, |
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Contractual interest expense:
|
|
|
|
|
|
|
|
||||||||
2013 Term Loan
|
$
|
1,047
|
|
|
$
|
—
|
|
|
$
|
1,800
|
|
|
$
|
—
|
|
Amortization of deferred financing fees:
|
|
|
|
|
|
|
|
||||||||
2013 Term Loan
|
60
|
|
|
—
|
|
|
99
|
|
|
—
|
|
||||
Amortization of debt discount:
|
|
|
|
|
|
|
|
||||||||
2013 Term Loan
|
46
|
|
|
—
|
|
|
76
|
|
|
—
|
|
||||
Other
|
7
|
|
|
—
|
|
|
21
|
|
|
—
|
|
||||
Total interest expense
|
$
|
1,160
|
|
|
$
|
—
|
|
|
$
|
1,996
|
|
|
$
|
—
|
|
•
|
Have a consolidated EBITDA (as defined in the Financing Agreement) amount greater than
$9.5 million
for the two consecutive fiscal quarters ending
March 31, 2014
;
|
•
|
Have a total leverage ratio (as defined in the Financing Agreement) of less than
2.39
to
1.00
for the quarter ended
March 31, 2014
. Our leverage ratio requirement decreases over time to
1.25
to
1.00
for the quarter ended
June 30, 2016
, and remains level thereafter;
|
•
|
Have a fixed charge ratio (as defined in the Financing Agreement) of greater than
1.20
to
1.00
for the two consecutive fiscal quarters ending
March 31, 2014
. Our fixed charge requirement remains level through the quarter ended
December 31, 2014
, after which it increases to
1.25
to
1.00
thereafter; and
|
•
|
Have no less than $10 million in unrestricted cash and cash equivalents at any time when the total leverage ratio is greater than 1.25 to 1.00.
|
|
|
|
Payments due by period
|
||||||||||||||||
Contractual Obligations
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
Thereafter
|
||||||||||
Long-term debt obligations
|
$
|
45,825
|
|
|
$
|
4,700
|
|
|
$
|
14,100
|
|
|
$
|
27,025
|
|
|
$
|
—
|
|
Interest on long-term debt obligations
|
14,609
|
|
|
3,949
|
|
|
9,356
|
|
|
1,304
|
|
|
—
|
|
|||||
Operating lease obligations
|
16,419
|
|
|
2,294
|
|
|
6,176
|
|
|
3,837
|
|
|
4,112
|
|
|||||
Total
|
$
|
76,853
|
|
|
$
|
10,943
|
|
|
$
|
29,632
|
|
|
$
|
32,166
|
|
|
$
|
4,112
|
|
|
LIFEVANTAGE CORPORATION
|
|
|
Date: May 6, 2014
|
/s/
Douglas C. Robinson
|
|
Douglas C. Robinson
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
Date: May 6, 2014
|
/s/
David S. Colbert
|
|
David S. Colbert
Chief Financial Officer
(Principal Financial Officer)
|
Exhibit
|
Description
|
|
|
10.1#
|
Commercial Supply Agreement dated January 31, 2014 between LifeVantage Corporation and Deseret Laboratories, Inc.
|
|
|
10.2
|
Amended and Restated Employment Agreement dated effective as of March 24, 2014 between LifeVantage Corporation and Douglas C. Robinson
|
|
|
10.3
|
First Amendment to Lease entered into as of March 24, 2014 between Sandy Park II L.L.C. and LifeVantage Corporation
|
|
|
31.1
|
Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a)
|
|
|
31.2
|
Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a)
|
|
|
32.1*
|
Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
32.2*
|
Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101**
|
The following financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 formatted in XBRL (extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets at March 31, 2014 and June 30, 2013; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three months and nine months ended March 31, 2014 and 2013; (iii) Unaudited Condensed Consolidated Statement of Stockholders’ Deficit for the nine months ended March 31, 2014; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2014 and 2013; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text.
|
#
|
The Company has requested confidential treatment for portions of this agreement. Accordingly, certain portions of this agreement have been omitted in the version filed with this report and such confidential portions have been filed with the Securities and Exchange Commission.
|
*
|
This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing
|
**
|
Users of this data are advised that pursuant to Rule 406T of Regulation S-T, this XBRL information is being furnished and not filed herewith for purposes of Section 18 of the Exchange, and Sections 11 or 12 of the Securities Act of 1933 and is not to be incorporated by reference into any filing, or part of any registration statement or prospectus, of LifeVantage Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
|
1 Year Lifevantage Chart |
1 Month Lifevantage Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions